JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
CALL
Cisco
CSCO
$479B
| $32.3M | 0.01% |
967,100
+237,500
| +33% | +$7.56M |
|
1177
Lamb Weston
LW
$7.19B
| $32.2M | 0.01% |
691,847
+320,752
| +86% | +$14.4M |
|
|
ALXN
1178
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $32.2M | 0.01% |
232,900
-32,100
| -12% | -$4.36M |
|
|
INFN
1179
DELISTED
Infinera Corporation Common Stock
INFN
| $32.2M | 0.01% |
3,664,481
+1,446,641
| +65% | +$13.9M |
|
1180
CNX Resources
CNX
$5.2B
| $31.9M | 0.01% |
2,327,051
+1,609,914
| +224% | +$20.7M |
|
1181
InterDigital
IDCC
$8.89B
| $31.9M | 0.01% |
426,142
-144,402
| -25% | -$10.6M |
|
1182
Brighthouse Financial
BHF
$3.5B
| $31.9M | 0.01% |
+528,378
| New | +$30.1M |
|
1183
Community Health Systems
CYH
$423M
| $31.9M | 0.01% |
4,228,000
+2,932,700
| +226% | +$22.8M |
|
1184
AerCap
AER
$23.8B
| $31.7M | 0.01% |
625,502
+69,512
| +13% | +$3.41M |
|
|
AGN.PRA
1185
DELISTED
Allergan plc
AGN.PRA
| $31.7M | 0.01% |
42,914
+1,929
| +5% | +$1.6M |
|
|
GXP
1186
DELISTED
Great Plains Energy Incorporated
GXP
| $31.6M | 0.01% |
1,041,330
+373,455
| +56% | +$11.4M |
|
1187
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$477M
| $31.6M | 0.01% |
521,136
-506
| -0.1% | -$30.1K |
|
|
BRSL
1188
Brightstar Lottery PLC
BRSL
$2.03B
| $31.5M | 0.01% |
1,283,370
-1,193,142
| -48% | -$24.4M |
|
1189
Neurocrine Biosciences
NBIX
$16.6B
| $31.5M | 0.01% |
530,248
-49,773
| -9% | -$2.63M |
|
1190
Spire
SR
$4.85B
| $31.5M | 0.01% |
418,128
-16,383
| -4% | -$1.22M |
|
|
BRSS
1191
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $31.5M | 0.01% |
924,293
-26,755
| -3% | -$820K |
|
|
INVX
1192
Innovex International
INVX
$1.97B
| $31.3M | 0.01% |
703,383
-323,250
| -31% | -$14.1M |
|
|
DHC
1193
Diversified Healthcare Trust
DHC
$2.14B
| $31.2M | 0.01% |
1,602,237
-4,126,686
| -72% | -$80.4M |
|
1194
Bank of Hawaii
BOH
$3.13B
| $31.2M | 0.01% |
375,605
+4,000
| +1% | +$324K |
|
1195
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $31.2M | 0.01% |
+208,500
| New | +$31.4M |
|
1196
Texas Roadhouse
TXRH
$13.7B
| $31.2M | 0.01% |
633,213
+77,807
| +14% | +$3.79M |
|
1197
ASML
ASML
$669B
| $31M | 0.01% |
181,744
-94,081
| -34% | -$14.4M |
|
1198
Northwest Natural Holdings
NWN
$2.12B
| $31M | 0.01% |
476,933
+15,930
| +3% | +$1.02M |
|
1199
PUT
General Motors
GM
$76.8B
| $30.9M | 0.01% |
761,900
+341,900
| +81% | +$12.5M |
|
1200
Gerdau
GGB
$9.7B
| $30.9M | 0.01% |
11,505,821
+2,857,238
| +33% | +$8.03M |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.